2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Gonorrhoea: new trials by email Literature Review of Gonorrhoea trials Research Report on Gonorrhoea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination Meningococcal Group B Vaccine, Placebo - Gonorrhoea | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 52 | 2021-11-01 | 2026-10-21 |
| Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea AZD0914, Ceftriaxone - Gonorrhoea | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 180 | 2014-11-25 | 2017-03-22 |
Gonorrhea (2) · Sexually Transmitted Diseases (1)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Communicable Diseases (2) · Genital Diseases (2) · Gram-Negative Bacterial Infections (2) · Infections (2) · Neisseriaceae Infections (2) · Sexually Transmitted Diseases, Bacterial (2) · Urogenital Diseases (2) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Sexually Transmitted Diseases (1)
4CMenB vaccine (1) · Ceftriaxone (1) · zoliflodacin (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2)
United States (2)
5UM1AI148576-05 (1)